Marta Palomo-Irigoyen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Marta Palomo-Irigoyen has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Ashwin Woodhoo
Gene Regulatory Control in Disease Laboratory, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), University of Santiago de Compostela, Santiago de Compostela, Spain
15 shared publications - Ainhoa Iglesias-Ara
Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country UPV/EHU, 48080 Bilbao, Spain
14 shared publications Ana M. Zubiaga
14 shared publications- Beatriz Gómez-Santos
Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU. Leioa, Biobizkaia Health Research Institute, Barakaldo, Spain
14 shared publications Daniela Mestre
14 shared publicationsDiego Sáenz de Urturi
14 shared publications
Latest Publications
- Open Access
- 11 April 2025
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 32 (10) , 1833-1844
Chronic skin and systemic inflammation modulated by S100A8 and S100A9 complexes
Increased expression of the homodimeric S100A8 (A8) and S100A9 (A9) alarmins and their Calprotectin (CP) antimicrobial hetero-complex has been reported in Inflammatory Skin Diseases (ISDs) such as Atopic Dermatitis (AD), but the functional consequences of this increase are not known. We evaluated the cell- and tissue-specific functions of A8 and A9 in the local and the extra-cutaneous manifestations of ISD using genetically engineered mouse models. The genes encoding for the A9 or A8 proteins were inactivated in epidermal cells or neutrophils in the JunB ∆ep genetic mouse model for AD. Overall, epidermal inactivation of A9 aggravated, while similar A8 inactivation ameliorated experimental ISD. Epidermal differentiation and skin inflammation was also ameliorated when A9 was inactivated in neutrophils or in all cells. However, complete A9 knock-out was associated with worsened systemic effects, such as neutrophilic inflammation and bone loss. In addition, the distal phalanges of the digits displayed increased A8 protein expression, SA overgrowth and bone destruction. Epidermal A8 inactivation ameliorated bone loss, but promoted bone destruction in the digits, likely through A8-positive neutrophilic infiltrates. These data show that site- and cell-type-specific A8 and A9 expression modulates chronic skin and systemic inflammation with distinct effects on the skin differentiation and on the musculoskeletal system. These findings pave the way for novel therapies targeting the divergent functions of A8 and A9 to restore epidermal homeostasis and prevent systemic complications.
- 11 April 2025
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 32 (10) , 1833-1844
Open AccessChronic skin and systemic inflammation modulated by S100A8 and S100A9 complexes
Increased expression of the homodimeric S100A8 (A8) and S100A9 (A9) alarmins and their Calprotectin (CP) antimicrobial hetero-complex has been reported in Inflammatory Skin Diseases (ISDs) such as Atopic Dermatitis (AD), but the functional consequences of this increase are not known. We evaluated the cell- and tissue-specific functions of A8 and A9 in the local and the extra-cutaneous manifestations of ISD using genetically engineered mouse models. The genes encoding for the A9 or A8 proteins were inactivated in epidermal cells or neutrophils in the JunB ∆ep genetic mouse model for AD. Overall, epidermal inactivation of A9 aggravated, while similar A8 inactivation ameliorated experimental ISD. Epidermal differentiation and skin inflammation was also ameliorated when A9 was inactivated in neutrophils or in all cells. However, complete A9 knock-out was associated with worsened systemic effects, such as neutrophilic inflammation and bone loss. In addition, the distal phalanges of the digits displayed increased A8 protein expression, SA overgrowth and bone destruction. Epidermal A8 inactivation ameliorated bone loss, but promoted bone destruction in the digits, likely through A8-positive neutrophilic infiltrates. These data show that site- and cell-type-specific A8 and A9 expression modulates chronic skin and systemic inflammation with distinct effects on the skin differentiation and on the musculoskeletal system. These findings pave the way for novel therapies targeting the divergent functions of A8 and A9 to restore epidermal homeostasis and prevent systemic complications.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Information from E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment
1-Supplementary methods 2-Supplementary Figure legends 3-Supplementary references
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Information from E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment
1-Supplementary methods 2-Supplementary Figure legends 3-Supplementary references